Kersen(SH:603626) Sou Hu Cai Jing·2025-12-09 01:36Core Viewpoint - Kosen Medical, established in July 2018 with a registered capital of 118 million yuan, is facing challenges in its business development due to external market changes and ongoing Sino-U.S. trade tensions, with limited synergy with its core operations [1] Group 1: Company Overview - Kosen Medical primarily engages in the processing and export of minimally invasive surgical instruments [1] - The company will no longer be included in the consolidated financial statements following the completion of the transaction with Yaolingke, a wholly-owned subsidiary of FSP Holdings Pte. Ltd [1] Group 2: Transaction Details - The transaction is expected to increase the company's investment income by approximately 600 million yuan in the fiscal year 2025, aiding in cash flow recovery and reducing financial pressure [1] - Proceeds from the transaction will be used to supplement working capital, aiming to optimize the company's asset structure and fully exit the medical business [1] Group 3: Strategic Focus - Kosen Technology, the parent company, focuses on precision die-casting, forging, stamping, CNC, and laser cutting processes, providing precision structural components for well-known international clients such as Apple, Huawei, Amazon, and Google [1] - The strategic shift aims to further concentrate on the consumer electronics sector, enhancing operational levels and quality [1]